Yield10 Bioscience (YTEN) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Yield10 Bioscience (NASDAQ:YTEN) from a hold rating to a strong-buy rating in a research note issued to investors on Saturday, Zacks.com reports. They currently have $1.50 price objective on the specialty chemicals company’s stock.

According to Zacks, “Yield10 Bioscience, Inc. is an agricultural bioscience company. It focuses on the development of disruptive technologies for improvement in crop yield to enhance global food security. The company is working on new approaches, to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism for better production. It operates primarily in Saskatoon, Saskatchewan, Canada. Yield10 Bioscience, Inc., formerly known as Metabolix, Inc., is based in Woburn, Massachusetts. “

Several other research analysts have also recently weighed in on YTEN. National Securities started coverage on shares of Yield10 Bioscience in a research report on Wednesday, January 23rd. They issued a buy rating and a $5.00 price objective for the company. Maxim Group set a $5.00 price objective on shares of Yield10 Bioscience and gave the stock a buy rating in a research report on Tuesday, March 26th.

Shares of YTEN opened at $1.19 on Friday. The company has a market capitalization of $14.84 million, a PE ratio of -1.29 and a beta of 3.33. Yield10 Bioscience has a one year low of $0.68 and a one year high of $2.00.

Yield10 Bioscience (NASDAQ:YTEN) last announced its earnings results on Monday, March 25th. The specialty chemicals company reported ($0.19) EPS for the quarter, topping the consensus estimate of ($0.21) by $0.02. Yield10 Bioscience had a negative return on equity of 107.12% and a negative net margin of 1,649.28%. The business had revenue of $0.14 million for the quarter. Research analysts anticipate that Yield10 Bioscience will post -0.41 earnings per share for the current fiscal year.

About Yield10 Bioscience

Yield10 Bioscience, Inc is an agricultural bioscience company, which focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.

Recommended Story: Hedge Funds

Get a free copy of the Zacks research report on Yield10 Bioscience (YTEN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.